beta 2-Microglobulin amyloidosis: effect of ESRF treatment modality and dialysis membrane type.
Van Ypersele de Strihou
C
C
University of Louvain Medical School, Cliniques Universitaires St-Luc, Department of Nephrology, Bruxelles, Belgium.
D000686:Amyloidosis / Q000209:etiology*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy*; D008567:Membranes, Artificial; D006435:Renal Dialysis; D001613:beta 2-Microglobulin / Q000378:metabolism*
D008567:Membranes, Artificial; D001613:beta 2-Microglobulin